DMT: What Is It, What Does Science Say, and Why Is Everyone Talking About It?

Few substances in the pharmacological world ignite as much fascination and controversy as DMT. It has been called “the spirit molecule,” a gateway to other dimensions, and a naturally occurring chemical that the brain may produce on its own. But what does the science actually say? Let’s break it down.

What Is DMT?

N,N-Dimethyltryptamine, or DMT, is a powerful psychedelic compound found in dozens of plant species across the globe and, intriguingly, in trace amounts in the human body itself. Structurally, it belongs to the tryptamine family, sharing a backbone with serotonin and melatonin. It has been used for centuries by indigenous communities in South America, primarily through ayahuasca, a ceremonial brew that combines DMT-containing plants with a monoamine oxidase inhibitor (MAOI) that allows the compound to be orally active.

When smoked or vaporized in its crystalline freebase form, DMT produces an extraordinarily intense but short lived experience typically lasting 5 to 20 minutes characterized by vivid geometric visuals, a sense of entering alternate realities, and encounters with what users often describe as sentient entities. It is classified as a Schedule I controlled substance in the United States and remains illegal in most countries, though research exemptions have become more accessible in recent years.

The Science Behind DMT

DMT primarily acts on serotonin receptors, particularly the 5-HT2A receptor, which is the same target implicated in the effects of other classical psychedelics like psilocybin and LSD. This receptor interaction is thought to underlie the hallucinogenic experience by disrupting the brain’s default mode network, the system responsible for self-referential thought and the sense of a stable, continuous “self.”

What makes DMT uniquely interesting is its endogenous nature. The human body synthesizes DMT via the enzyme indolethylamine-N-methyltransferase (INMT), and the compound has been detected in human blood, urine, and cerebrospinal fluid. This has led to bold hypotheses: could DMT function as a natural neurotransmitter? Could it play a role in dreaming, consciousness, or even near-death experiences? These remain open and hotly debated questions.

Research published in Translational Psychiatry demonstrated that DMT administration activates the subgranular zone of the hippocampal dentate gyrus, a key neurogenic niche promoting the growth of new neurons. Mice treated with DMT also showed improved performance on memory tasks, suggesting that the compound’s neurogenic effects may have functional consequences. This appears to involve the sigma-1 receptor (S1R), as blocking S1R eliminated the neurogenic effect entirely.

The Hype: Mysticism, Near-Death Experiences, and Pop Culture

Much of DMT’s cultural mystique was amplified by Rick Strassman’s landmark 1990s clinical trials at the University of New Mexico, the first government-approved psychedelic research in decades, and his subsequent 2000 book DMT: The Spirit Molecule. Strassman proposed that the pineal gland might secrete DMT during birth, death, and deep meditative states, effectively acting as a biological portal to non-ordinary consciousness.

This idea captured the public imagination in a massive way. DMT experiences frequently involve contact with what users describe as “machine elves,” angelic beings, or interdimensional intelligences accounts remarkably consistent across cultures and backgrounds. The overlap between DMT-induced states and near-death experiences (NDEs) has been noted by researchers, fueling speculation that endogenous DMT might be released at the moment of death.

While these ideas remain speculative and unproven, they have powered an enormous cultural wave from Joe Rogan’s podcast to documentary films, underground retreat circuits, and the broader psychedelic renaissance now gaining mainstream traction.

Current Research: Where Is the Science Heading?

The scientific community is increasingly taking DMT seriously as a therapeutic candidate and as a tool for understanding consciousness. Here are some of the most exciting directions in current research:

Antidepressant effects: Ayahuasca which contains DMT as its primary psychoactive component has shown rapid antidepressant effects in multiple clinical trials, with double-blind randomized controlled trials reporting significant reductions in depression scores compared to placebo within days of administration. Notably, these effects appear far faster than conventional antidepressants, which typically require weeks to take effect.
Neuroplasticity and neurogenesis: Multiple studies suggest that DMT promotes neuroplasticity the brain’s ability to form new connections via mechanisms involving the TrkB receptor (the same target as ketamine and BDNF). A 2024 narrative review in Brain Sciences highlighted DMT’s implications in promoting neuroplasticity through neuritogenesis, and its potential relevance to neurodegeneration.
Extended-state DMT: A novel clinical approach involves administering DMT intravenously at a controlled rate to maintain a prolonged, stable psychedelic state making therapeutic work possible within the experience itself. Imperial College London has been pioneering this paradigm.
Consciousness science: DMT is being used as a probe to investigate the neural correlates of consciousness, ego dissolution, and the nature of subjective experience areas that have traditionally been resistant to empirical study.
Near-death experience models: Researchers are exploring whether endogenous DMT release could account for the phenomenology of NDEs, though this hypothesis remains difficult to test and is viewed skeptically by many neuroscientists.

While we are still far from a complete picture, DMT is no longer the fringe topic it once was. Clinical trials are multiplying, regulatory frameworks are slowly adapting, and the scientific literature is growing rapidly.

Scents of Science

Think different.